MONASH IVF GROUP LIMITED — M&A Activity 2024

Mar 3, 2024

==> picture [596 x 118] intentionally omitted <==

ASX Announcement

Monash IVF Group Limited (ASX:MVF)

4 March 2024

Completion of Fertility North Acquisition

Monash IVF Group Limited (ASX: MVF, the “Company” or “Monash IVF”) is pleased to announce completion of the Fertility North Holdings Pty Ltd (“Fertility North” or the “Business”) acquisition as announced on 19 December 2023. Fertility North is a leading provider of fertility services to Perth’s northern suburbs.

In commenting on the acquisition of Fertility North, Monash IVF’s Chief Executive Officer & Managing Director Mr Michael Knaap said: “ We are very excited to be expanding our presence in the fast-growing Perth market through the acquisition of Fertility North. We believe the businesses of Fertility North and our existing Monash IVF business in Perth are complementary to each other, servicing different catchment areas, with Fertility North servicing Perth’s northern suburbs and Monash IVF West Leederville (formerly PIVET Medical Centre) servicing central and southern Perth. The transaction structure mutually aligns Monash IVF and Fertility North to grow the Fertility North business, and rewards Fertility North’s shareholders for delivering on its growth targets .”

Fertility North co-founder Doctor Jay Natalwala commented “ Joining forces with Monash IVF represents the culmination of over 20 years of dedication to building one of Perth’s leading IVF clinics . We could not have achieved this milestone without the amazing team we have built, and we look forward to continuing to support our patients and community as part of the larger Monash IVF Group ”.

Authorised by the Chairman and Managing Director

For further information please contact:

Michael Knaap

Chief Executive Officer & Managing Director Monash IVF Group T: +61 3 9420 8235

Malik Jainudeen

Chief Financial Officer & Company Secretary Monash IVF Group +61 3 9420 8235

-Ends-